CIK 0001971387 · <br>Emerging growth company
Liminatus Pharma, Inc.
Sign in to watch- Ticker
- LIMN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 213-273-5453
- Business address
- 12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
- Former names
- Iris Parent Holding Corp.
Securities
- LIMN Class A Common Stock Nasdaq
- LIMNW Warrants Nasdaq
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- DRS Other Draft Registration Statement
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- NT 10-Q Other NT 10-Q
- 8-K12B Other 8-K12B
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- DRS Other Draft Registration Statement
Page 1 of 1 · 13 filings